Vaccine Development Insights

Jessica shares her emotional response to the remarkable efficacy of the COVID-19 vaccines, highlighting their over 90% effectiveness compared to initial expectations. She emphasizes the extensive research behind mRNA technology, which has been in development for decades, and discusses the rapid timeline from virus genome sequencing to the first vaccine trials. The collaboration and urgency in the scientific community allowed for unprecedented speed without compromising safety.